RIMSTAR® clinical trials

RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

This study is testing new combinations of existing medicines for lung tuberculosis. Researchers want to see if these new combinations work better and are safe, especially for patients whose spit samples still show bacteria. It's an early-stage study to gather important information.